Abstract
This review covers the efficacy, side effects, and toxicity of various classes of antidepressants: tricyclics (TCAs), monoamine oxidase inhibitors (MAOIs), and second generation antidepressants including the selective inhibitors of serotonin reuptake (SSRIs). Also reviewed are newer drugs such as moclobemide, a reversible inhibitor of monoamine oxidase (RIMA), and venlafaxine, a drug that inhibits the uptake of both norepinephrine and serotonin (similar in this respect to a number of the TCAs) but has a side‐effect profile more like that of the SSRIs. Depression 2:1–19 (1994). © 1994 Wiley‐Liss, Inc.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-19 |
| Number of pages | 19 |
| Journal | Depression |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1994 |
Keywords
- antidepressants
- moclobemide
- monoamine oxidase inhibitors
- second generation antidepressants
- selective serotonin reuptake inhibitors
- tricyclic antidepressants
- venlafaxine
ASJC Scopus subject areas
- Psychiatry and Mental health